GSK-AK1102365

Study Sponsor: GSK

Study Title

Clinical evaluation of 323U66 SR in patients with depression - Placebo-controlled, double-blind, comparative study in patients with depression who did not respond sufficiently to selective serotonin re-uptake inhibitors

Medicine or Vaccine (generic name)

bupropion

Sponsor Identification Number

AK1102365

Trial Registry Identification Number(#'s)

NCT00296517

Medical Condition

Depressive Disorder

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=AK1102365

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00296517

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A reporting and analysis plan and a protocol are not available for this study. An annotated and a blank case report form are not available for this study. A clinical study report is not available for this study because an English language version was not created.

Date Added to this Site

September 2019